In a statement, the European medicines regulator gave the green light for a third dose of the Pfizer/BioNTech vaccine for people over 18 years.

“The Committee for Medicinal Products for Human Use (CHMP) has evaluated data for Comirnaty showing a rise in antibody levels when a booster dose is given approximately 6 months after the second dose in people from 18 to 55 years old. On the basis of this data, the Committee concluded that booster doses may be considered at least 6 months after the second dose for people aged 18 years and older,” the EMA said in an official statement.

The EMA also concluded that an additional dose of the vaccines Covid-19 Comirnaty (Pfizer/BioNTech) and Spikevax (Moderna) can be given to people with severely compromised immune systems at least 28 days after their second dose.

In Luxembourg, the government is relying on the advice of the Higher Council for Infectious Diseases (CSMI) to put in place a strategy to combat the epidemic. The CSMI is also very attentive to the recommendations of the European regulator.

This article  on Paperjam. It has been translated and edited for Delano.